Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Fresenius Medical Care gains marketing rights to TRK-820

April 5, 2012

LabCorp licenses diagnostic technology for Alzheimer's disease

April 5, 2012

Ajinomoto in-licenses IBAT inhibitor

April 4, 2012

Amgen and AstraZeneca to jointly develop inflammation portfolio candidates

April 4, 2012

Forest Laboratories acquires intellectual property from Janssen

April 4, 2012

PolyTherics and Spirogen to collaborate on novel ADCs for cancer

April 3, 2012

Synageva BioPharma and Mitsubishi Tanabe Pharma expand collaboration

April 3, 2012

Novartis Nanobody candidate clear to enter phase I trial

April 3, 2012

Minophagen granted additional rights to bexarotene

April 2, 2012

Myriad Genetics and Cephalon enter agreement for mutation testing in phase I/II study

April 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...